SE7500130L - - Google Patents

Info

Publication number
SE7500130L
SE7500130L SE7500130A SE7500130A SE7500130L SE 7500130 L SE7500130 L SE 7500130L SE 7500130 A SE7500130 A SE 7500130A SE 7500130 A SE7500130 A SE 7500130A SE 7500130 L SE7500130 L SE 7500130L
Authority
SE
Sweden
Prior art keywords
influenza
components
virus
type
cationic detergent
Prior art date
Application number
SE7500130A
Other languages
Unknown language ( )
English (en)
Other versions
SE427238B (sv
Inventor
H Bachmayer
G Schmidth
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7500130L publication Critical patent/SE7500130L/
Publication of SE427238B publication Critical patent/SE427238B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
SE7500130A 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter SE427238B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (cs) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
SE7500130L true SE7500130L (cs) 1975-07-15
SE427238B SE427238B (sv) 1983-03-21

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500130A SE427238B (sv) 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter

Country Status (27)

Country Link
JP (2) JPS58407B2 (cs)
AT (1) AT345449B (cs)
AU (1) AU500250B2 (cs)
BE (1) BE824372A (cs)
CA (1) CA1049406A (cs)
CH (1) CH589453A5 (cs)
CS (1) CS191254B2 (cs)
DD (1) DD116239A5 (cs)
DE (1) DE2500785B2 (cs)
DK (1) DK140003B (cs)
ES (1) ES433759A1 (cs)
FI (1) FI54053C (cs)
FR (1) FR2257305B1 (cs)
GB (1) GB1498261A (cs)
HK (1) HK56380A (cs)
HU (1) HU173920B (cs)
IE (1) IE40794B1 (cs)
IL (1) IL46426A (cs)
MY (1) MY8100204A (cs)
NL (1) NL166622C (cs)
NO (1) NO143128C (cs)
PH (1) PH14458A (cs)
PL (1) PL93689B1 (cs)
SE (1) SE427238B (cs)
SU (1) SU616997A3 (cs)
YU (1) YU41289B (cs)
ZA (1) ZA75259B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
DK1951296T4 (da) * 2005-11-01 2014-09-01 Novartis Vaccines & Diagnostic Celleafledte viral vacciner med lave niveauer af restcelle-DNA
RU2496519C2 (ru) * 2007-08-28 2013-10-27 Бакстер Интернэшнл Инк. Способ получения препарата, содержащего вирусные антигены, и применение препарата
CN105745218B (zh) 2013-11-15 2020-11-06 诺华股份有限公司 去除残留细胞培养杂质

Also Published As

Publication number Publication date
SU616997A3 (ru) 1978-07-25
DD116239A5 (cs) 1975-11-12
FR2257305A1 (cs) 1975-08-08
FI54053B (fi) 1978-06-30
JPS58407B2 (ja) 1983-01-06
MY8100204A (en) 1981-12-31
BE824372A (fr) 1975-07-14
HK56380A (en) 1980-10-16
NL7500301A (nl) 1975-07-16
DK1475A (cs) 1975-09-01
JPS50100224A (cs) 1975-08-08
CS191254B2 (en) 1979-06-29
DK140003B (da) 1979-06-05
DK140003C (cs) 1979-10-29
ATA21475A (de) 1978-01-15
CA1049406A (en) 1979-02-27
FI54053C (fi) 1978-10-10
DE2500785A1 (de) 1975-07-31
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
AT345449B (de) 1978-09-11
HU173920B (hu) 1979-09-28
ES433759A1 (es) 1977-02-16
DE2500785B2 (de) 1980-01-03
YU5875A (en) 1984-04-30
IE40794L (en) 1975-07-14
AU500250B2 (en) 1979-05-17
IL46426A (en) 1978-01-31
NO750031L (cs) 1975-08-11
SE427238B (sv) 1983-03-21
PL93689B1 (cs) 1977-06-30
AU7730575A (en) 1976-07-15
DE2500785C3 (cs) 1980-09-11
NL166622B (nl) 1981-04-15
CH589453A5 (cs) 1977-07-15
FI750014A7 (cs) 1975-07-15
NO143128B (no) 1980-09-15
FR2257305B1 (cs) 1982-03-19
NL166622C (nl) 1981-09-15
PH14458A (en) 1981-07-29
IE40794B1 (en) 1979-08-15
GB1498261A (en) 1978-01-18
IL46426A0 (en) 1975-04-25
YU41289B (en) 1987-02-28
JPS56127319A (en) 1981-10-06
JPS6035326B2 (ja) 1985-08-14

Similar Documents

Publication Publication Date Title
Schierman et al. Adjuvant activity of erythrocyte isoantigens
Cella et al. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
HU9401056D0 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
SE7500130L (cs)
US3674864A (en) Process for stabilizing preparations of interfering viruses
Hirst et al. A new method for concentrating influenza virus from allantoic fluid
Bang Filamentous forms of Newcastle virus
ES469225A1 (es) Procedimiento para potenciar la accion de las vacunas.
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ES430415A1 (es) Un procedimiento para preparar una vacuna de virus de la gripe atenuado.
GB2001326A (en) Glycoproteins from paramyxovirus and vaccines therefrom
Mims Rift Valley fever virus in mice. II. Adsorption and multiplication of virus
IE40221B1 (en) Influenza vaccines
AU5573196A (en) A pluripotent vaccine against enveloped viruses
GB1140316A (en) Influenza virus sub-unit vaccine
Greer et al. Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits
CA1270438A (en) Influenza vaccine
GB1327870A (en) Process for the manufacture of a vaccine against infectious bursitis of chickens
GB777018A (en) Poliomyelitis vaccine products and methods for preparing the same
郭元吉 et al. Influenza C virus isolated from pigs in China
PT100460A (pt) Partiiculas derivadas de virus de herpes e vacinas que as contem
WO2024186901A3 (en) Broadly reactive immunogens of influenza h3 virus, compositions and methods of use thereof
AR120296A1 (es) Vacuna de partículas de virus de tipo chikungunya y sus métodos de uso
ES384308A3 (es) Procedimiento para la preparacion de vacunas antigripales.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500130-5

Effective date: 19940810

Format of ref document f/p: F